Partner at White & Case LLP
Charles Larsen is an IP partner based in White & Case’s Boston office, with a dual practice in London. He concentrates his practice on providing strategic patent advocacy and is licensed to practise before the US Patent and Trademark Office, the European Patent Office (EPO), the US district courts and the UK High Court.
His patent practice includes advising on multi-jurisdictional disputes and conducting patent validity, infringement and freedom-to-operate studies, as well as IP due diligence, in the United States and Europe. He also advises clients in inter partes reviews, European oppositions, other post-grant proceedings, and US and European litigation strategies. He has served as counsel of record in 23 Patent Trial and Appeal Board proceedings and re-examinations, and in numerous EPO oppositions.
With a unique trans-Atlantic approach to patent disputes in the United States and Europe, Mr Larsen is also a leading voice in the United States on preparing US companies for Europe’s Unified Patent Court.
Mr Larsen’s practice also includes portfolio due diligence for equity investments and acquisitions, working with clients to structure their transactions to address the IP risks involved. A significant part of his practice involves advising clients on developing and positioning strategic patent portfolios for licensing and litigation.
Mr Larsen has advised on a wide range of engineering and life sciences applications, including medical technologies, chemistry and pharmaceuticals, drug delivery systems, consumer electronics and signal processing, combustion and energy technology, fluid mechanics, manufacturing processes, software and hardware. In the medical technology sector, his experience spans a number of areas, including implantable heart pumps, respiratory systems, orthopedics, neuromonitoring, spine technology, electrical stimulation, vascular technology, healthcare informatics, biological manufacturing and diagnostics.
Additionally, Mr Larsen provides counsel to clients outside of the life sciences sector in industries such as the consumer products, finance, media and technology industries.